FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20201022E00174
1. Date of relevant event: 09/10/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01952
4. Name of listed corporation: Everest Medicines Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 283,690,389
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) FU
(Other names) Wei
10. Name of director (Chinese): 傅唯 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
 
 
2501Other (you must describe the capacity in the Supplementary Information box)
 		 131,872,215         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position131,872,21546.48
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position122,340,215
2501Other (you must describe the capacity in the Supplementary Information box)
Long position9,532,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Vistra Trust (Singapore) Pte. LimitedSingaporeWei Fu100.00N
Long position131,872,215
Nova Aqua LimitedBritish Virgin IslandsVistra Trust (Singapore) Pte. Limited100.00N
Long position131,872,215
TF Capital II, LtdCayman IslandsNova Aqua Limited47.83N
Long position50,000,000
C-Bridge Capital GP, Ltd.Cayman IslandsTF Capital II, Ltd38.34N
Long position50,000,000
C-Bridge Healthcare Fund GP II, L.P.Cayman IslandsC-Bridge Capital GP, Ltd.100.00N
Long position50,000,000
C-Bridge Healthcare Fund II, L.P.Cayman IslandsC-Bridge Healthcare Fund GP II, L.P.100.00N
Long position50,000,000
C-Bridge Investment Everest Limited3rd Floor, J&C Building, P.O. Box 933, Road Town, Tortola, VG1110, British Virgin IslandsC-Bridge Healthcare Fund II, L.P.100.00Y
Long position50,000,000
TF Capital IV, LtdCayman IslandsNova Aqua Limited100.00N
Long position53,639,823
C-Bridge Capital GP IV, Ltd.Maples Corporate Services Limited, P. O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsTF Capital IV, Ltd100.00N
Long position53,639,823
C-Bridge Healthcare Fund GP IV, L.P.Cayman IslandsC-Bridge Capital GP IV, Ltd.100.00N
Long position53,639,823
C-Bridge Healthcare Fund IV, L.P.Cayman IslandsC-Bridge Healthcare Fund GP IV, L.P.100.00N
Long position53,639,823
C-Bridge IV Investment Two LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.97.09Y
Long position38,362,045
C-Bridge IV Investment Nine LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.100.00Y
Long position15,277,778
C-Bridge Value Creation LimitedGrand Pavilion Commercial Centre, Suite 24, 802 West Bay Road, P.O. Box 10281, Grand Cayman KY1-1003, Cayman IslandsNova Aqua Limited100.00N
Long position24,005,392
Everest Management Holding Co., LtdCayman IslandsC-Bridge Value Creation Limited78.32Y
Long position24,005,392
C-Bridge IV Investment Sixteen LimitedBritish Virgin IslandsNova Aqua Limited100.00Y
Long position4,227,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
(Private trust)Addresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position131,872,215
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: For box 27, the long position of 9,532,000 shares represents the shares lent to Goldman Sachs International pursuant to a stock borrowing agreement, of which C-Bridge Investment Everest Limited is the lender, entered into prior to 09/10/2020 in connection with the initial public offering of shares of the listed corporation.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 22/10/2020
(dd/mm/yyyy)